Increased risk for incisional hernia following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Introduction: The incidence of incisional hernias (IH) after midline laparotomy varies from 11% to 20%. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is potentially prone to hernias because a Xiphoid to pubis laparotomy incision performed on patients who have undergone previous abdominal surgeries with the addition of chemotherapy and its related adverse effects.

Methods: We performed a retrospective analysis on a prospectively maintained single institution database from March 2015 to July 2020.